{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:36:15Z","timestamp":1790332575612,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.euo.2023.01.003","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T21:55:29Z","timestamp":1674856529000},"page":"160-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer\u2014A Report of a Movember International Consensus Meeting"],"prefix":"10.1016","volume":"6","author":[{"given":"Caroline M.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Withington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Briers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis I.","family":"Chinegwundoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Cooperberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret I.","family":"Fitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Frydenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoom A.","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netty","family":"Kinsella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.L.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lichty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon A.","family":"Mahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Mastris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita V.","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel W.D.","family":"Merriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Van Hemelrijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nynikka R.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique J.","family":"Roobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Schraidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille E.","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Minhaj","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare M.C.","family":"Tempany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Villers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Wolinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2023.01.003_b0005","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.eururo.2015.06.012","article-title":"Compliance rates with the Prostate Cancer Research International Active Surveillance (PRIAS) protocol and disease reclassification in noncompliers","volume":"68","author":"Bokhorst","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.21037\/tau.2017.12.24","article-title":"Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices","volume":"7","author":"Kinsella","year":"2018","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bju.14106","article-title":"Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date","volume":"121","author":"Bruinsma","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.01.003_b0020","unstructured":"Clarke N, Payne H. National Prostate Cancer Audit Annual Report 2019. NPCA.org.uk. January 2020. https:\/\/www.npca.org.uk\/content\/uploads\/2020\/01\/NPCA-Annual-Report-2019_090120.pdf."},{"key":"10.1016\/j.euo.2023.01.003_b0025","unstructured":"Clarke N, Payne H. National Prostate Cancer Audit Annual Report 2020. NPCA.org.uk. January 2021. https:\/\/www.npca.org.uk\/content\/uploads\/2021\/01\/NPCA-Annual-Report-2020_Final_140121.pdf."},{"key":"10.1016\/j.euo.2023.01.003_b0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41391-019-0157-y","article-title":"Contemporary national trends in prostate cancer risk profile at diagnosis","volume":"23","author":"Fletcher","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2023.01.003_b0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-149-3-200808050-00008","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"149","author":"U.S. Preventive Services Task Force","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euo.2023.01.003_b0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2018.02.026","article-title":"Factors influencing men's choice of and adherence to active surveillance for low-risk prostate cancer: a mixed-method systematic review","volume":"74","author":"Kinsella","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0045","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.eururo.2018.10.025","volume":"75","author":"Van Hemelrijck","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/JU.0000000000001700","article-title":"The Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. Risk-based selection for active surveillance: results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) initiative","volume":"206","author":"Bruinsma","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.euros.2021.09.012","article-title":"Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. Comparison of characteristics, follow-up and outcomes of active surveillance for prostate cancer according to ethnicity in the GAP3 Global Consortium database","volume":"34","author":"Beckmann","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2023.01.003_b0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.euros.2021.11.006","volume":"35","author":"Olivier","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2023.01.003_b0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrurol.2017.26","article-title":"Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer\u2014results of a modified Delphi consensus procedure","volume":"14","author":"Bruinsma","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0070","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2019.09.020","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE study)","volume":"76","author":"Lam","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.eururo.2021.12.007","article-title":"Systematic review of active surveillance for clinically localised prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy","volume":"81","author":"Willemse","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0080","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0140-6736(21)01020-5","article-title":"Announcing the Lancet Commission on Prostate Cancer","volume":"397","author":"James","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2023.01.003_b0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41585-020-0324-x","article-title":"PIONEER consortium. Introducing PIONEER: a project to harness big data in prostate cancer research","volume":"17","author":"Omar","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0090","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1111\/bju.13854","article-title":"A core outcome set for localised prostate cancer effectiveness trials","volume":"120","author":"MacLennan","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.01.003_b0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.euo.2021.10.004","article-title":"Standardising the assessment of patient-reported outcome measures in localised prostate cancer. A systematic review","volume":"5","author":"Ratti","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.01.003_b0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2022.01.042","article-title":"Updating and integrating core outcome sets for localised, locally advanced, metastatic, and nonmetastatic castration-resistant prostate cancer: an update from the PIONEER consortium","volume":"81","author":"Beyer","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0105","unstructured":"Siddiqui M. Prioritization of CER\/PCOR on prostate cancer active surveillance: community consensus initiative. PCORI.org. https:\/\/www.pcori.org\/research-results\/2021\/prioritization-cerpcor-prostate-cancer-active-surveillance-community-consensus-initiative."},{"key":"10.1016\/j.euo.2023.01.003_b0110","unstructured":"Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND\/UCLA appropriateness method user's manual. RAND.org. 2001. https:\/\/www.rand.org\/content\/dam\/rand\/pubs\/monograph_reports\/2011\/MR1269.pdf."},{"key":"10.1016\/j.euo.2023.01.003_b0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","article-title":"Prostate Imaging Quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial","volume":"3","author":"Giganti","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.01.003_b0125","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.eururo.2016.06.011","article-title":"Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations\u2014a report of a European school of Oncology Task Force","volume":"71","author":"Moore","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.juro.2016.02.2963","article-title":"How active is active surveillance? Intensity of followup during active surveillance for prostate cancer in the United States","volume":"196","author":"Loeb","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.01.003_b0135","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.euo.2018.09.007","article-title":"A single educational seminar increases confidence and decreases dropout from active surveillance by 5 years after diagnosis of prostate cancer","volume":"2","author":"Kinsella","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.01.003_b0140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.eururo.2020.03.035","article-title":"Five-year outcomes of magnetic resonance imaging-based active surveillance for prostate cancer\u2014a large cohort study","volume":"78","author":"Stavrinides","year":"2020","journal-title":"Eur Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:49:01Z","timestamp":1762876141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931123000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2588931123000020"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2023.01.003","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer\u2014A Report of a Movember International Consensus Meeting","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2023.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}